Related Experiment Video
Updated: Dec 28, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Treatment strategies for hypertension in patients with type 1 diabetes
Alexandra Katsimardou1, Konstantinos Imprialos1, Konstantinos Stavropoulos1
1Department of Internal Medicine, Aristotle University , Thessaloniki, Greece.
Insights
Hypertension impacts about one-third of individuals with type 1 diabetes mellitus (T1DM), yet blood pressure control remains low. Treatment guidelines recommend lifestyle changes and antihypertensive therapy, targeting lower systolic blood pressure for better outcomes.
Area of Science:
- Endocrinology
- Cardiology
- Nephrology
Background:
- Type 1 diabetes mellitus (T1DM) is an autoimmune condition causing absolute insulin deficiency.
- Hypertension is a frequent comorbidity in T1DM, contributing to cardiovascular disease and microvascular complications.
Purpose of the Study:
- To review current definitions, epidemiology, and prevalence of hypertension in T1DM.
- To outline contemporary therapeutic strategies for managing hypertension in T1DM patients.
Main Methods:
- Literature review focusing on hypertension in T1DM.
- Analysis of epidemiological data and prevalence rates.
- Evaluation of current treatment guidelines and therapeutic options.
Main Results:
- Approximately one-third of T1DM patients have hypertension, with higher rates in older individuals and those with longer disease duration.
- Blood pressure control rates in T1DM patients with hypertension are notably low.
- Treatment recommendations include lifestyle modifications and antihypertensive therapy, with specific targets for systolic blood pressure.
Conclusions:
- Initiate antihypertensive treatment for T1DM patients with blood pressure above 140/90 mmHg, aiming for systolic pressure below 130 mmHg.
- Consider lower systolic blood pressure targets (<130 mmHg) for T1DM patients with established cardiovascular disease or diabetic nephropathy.
- Renin-angiotensin-aldosterone system inhibitors are recommended as initial pharmacotherapy; further research is needed on optimal treatment strategies.
Introduction:
Type 1 diabetes mellitus (T1DM) is a chronic, autoimmune disease that is characterized by total absence of insulin production. Hypertension is a common comorbidity in T1DM with complex pathophysiology, while it is also a well-recognized risk factor for the development of cardiovascular disease (CVD), as well as other microvascular diabetic complications.
Areas Covered:
The purpose of this review is to present the current definitions, epidemiological data and prevalence rates of hypertension in T1DM, as well as to describe current therapeutic options.
Expert Opinion:
Hypertension affects around a third of the type 1 diabetic population, with higher prevalence rates in older individuals with longer disease duration. Although hypertension affects a substantial proportion of T1DM individuals, blood pressure control rates are disappointingly low. Alongside lifestyle modification, antihypertensive treatment should be initiated in those with blood pressure above 140/90 mmHg, with a systolic blood pressure target of 130 mmHg and lower, if tolerated. In those with established CVD or diabetic nephropathy, systolic blood pressure targets below 130 mmHg should be pursued. Initial pharmacotherapy should consist of a renin-angiotensin-aldosterone system inhibitor. There is an urgent need for good quality data regarding proper antihypertensive treatment initiation, optimal BP targets and optimal antihypertensive treatment for better clinical outcomes.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Heart Failure V: Medical Management

